Financial Information of Amwill Healthcare Limited IPO
The Revenues from operations for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 2,324.71 Lakh, ₹ 4,428.41 Lakh, ₹ 3,028.25 Lakh and ₹ 2,761.54 Lakh respectively. The EBITDA for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 893.04 Lakh, ₹ 1,700.27 Lakh, ₹ 441.19 Lakh, and ₹ 366.22 Lakh, respectively. The Profit after Tax for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 651.66 Lakh, ₹ 1,253.63 Lakh, ₹ 311.44 Lakh, and ₹ 257.37 Lakh respectively. This indicates a steady growth in financial performance.
| Period Ended | Sep 30, 2024 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|
| Reserve of Surplus | 807.52 | 1,710.86 | 457.23 | 145.79 |
| Total Assets | 2,888.66 | 1,898.01 | 1,239.43 | 658.75 |
| Total Borrowings | 26.40 | 28.82 | 30.35 | 26.61 |
| Fixed Assets | 109.28 | 55.35 | 48.95 | 38.67 |
| Cash | 1,318.19 | 327.78 | 685.36 | 240.8 |
| Net Borrowing | -1,291.79 | -298.96 | -655.01 | -214.19 |
| Revenue | 2,324.71 | 4,428.41 | 3,028.25 | 2,761.54 |
| EBITDA | 893.04 | 1,700.27 | 441.19 | 366.22 |
| PAT | 651.66 | 1,253.63 | 311.44 | 257.37 |
| EPS | 4.18 | 8.04 | 2 | 1.65 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Offer, given in FINANCIAL EXPRESS.
Copyright @2020 Design & Developed by Info Web Software